Fineline Cube

Follow:
14778 Articles
Fangzhou Inc. Partners with BMS to Innovate Digital Medicine Platform
CompanyDeals

Fangzhou Inc. Partners with BMS to Innovate Digital Medicine Platform

Sanofi and Corxel Pharmaceuticals Partner for Aficamten in Greater China Rights
CompanyDigital

Sanofi and Corxel Pharmaceuticals Partner for Aficamten in Greater China Rights

HOB Biotech Group Corp. Acquired by Sino Biopharmaceutical Ltd for IVD Synergies
CompanyDeals

HOB Biotech Group Corp. Acquired by Sino Biopharmaceutical Ltd for IVD Synergies

Joincare Pharmaceutical's JKN2403 Gains NMPA Approval for COPD Clinical Trials
CompanyDrug

Joincare Pharmaceutical’s JKN2403 Gains NMPA Approval for COPD Clinical Trials

Sino Biopharmaceutical Ltd. Files for Benmelstobart and Anlotinib Combination Therapy in ASPS Treatment
CompanyDrug

Sino Biopharmaceutical Ltd. Files for Benmelstobart and Anlotinib Combination Therapy in ASPS Treatment

HighTide Therapeutics and SSY Group Ltd Join Forces to Tackle Metabolic and Aging Diseases
CompanyDeals

HighTide Therapeutics and SSY Group Ltd Join Forces to Tackle Metabolic and Aging Diseases

AIM Vaccine Co., Ltd Receives NMPA Clearance for Innovative Cell-Based Influenza Vaccine
CompanyDrug

AIM Vaccine Co., Ltd Receives NMPA Clearance for Innovative Cell-Based Influenza Vaccine

Henlius Biotech Expands Partnership with Palleon Pharmaceuticals for Autoimmune Disease Treatment
CompanyDeals

Henlius Biotech Expands Partnership with Palleon Pharmaceuticals for Autoimmune Disease Treatment

AIM Vaccine Co., Ltd Receives NMPA Approval for Second-Gen Tetanus Vaccine Clinical Trial
CompanyDrug

AIM Vaccine Co., Ltd Receives NMPA Approval for Second-Gen Tetanus Vaccine Clinical Trial

MSD's Clesrovimab for Infant RSV Protection: FDA Accepts BLA for Review
CompanyDrug

MSD’s Clesrovimab for Infant RSV Protection: FDA Accepts BLA for Review

Photys Therapeutics and Novo Nordisk Partner to Develop Proximity-Based Therapies for Cardiometabolic Diseases
CompanyDeals

Photys Therapeutics and Novo Nordisk Partner to Develop Proximity-Based Therapies for Cardiometabolic Diseases

Merck to Acquire HUB Organoids Holding B.V., Advancing Organoid Technology in Drug Development
CompanyDeals

Merck to Acquire HUB Organoids Holding B.V., Advancing Organoid Technology in Drug Development